APP and early-onset autosomal dominant Alzheimer disease: Amyloid precursor protein (APP) has been studied mostly in the context of Alzheimer’s disease (AD), however, recent reports show its importance in cancer (Wozniak and Ludwig, 2018; Wu et al., 2020) and RA (Kuroda et al., 2019).